Market Tracker

07/29 6:45pm ET

Agenus Inc (NASDAQ:AGEN)

5.55
Delayed Data
As of Jul 29
 +0.17 / +3.16%
Today’s Change
2.61
Today|||52-Week Range
8.69
+22.25%
Year-to-Date
Agenus (AGEN) Posts Narrower than Expected Loss in Q2
Jul 29 / Zacks.com - Paid Partner Content
Agenus (AGEN): What's Ahead for the Stock in Q2 Earnings?
Jul 25 / Zacks.com - Paid Partner Content
Agenus (AGEN) Reports Narrower-than-Expected Q2 Loss
Jul 28 / Zacks.com - Paid Partner Content
Is Agenus or Ariad Pharmaceuticals the Better Long-Term Buy?
Jul 19 / MotleyFool.com - Paid Partner Content
Watch for Drug Stocks Earnings on Jul 28: BMY, CELG & More
Jul 27 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close5.38
Today’s open5.42
Day’s range5.36 - 5.70
Volume2,312,904
Average volume (3 months)1,031,478
Market cap$426.5M
Dividend yield--
Data as of 4:14pm ET, 07/29/2016

Growth & Valuation

Earnings growth (last year)-59.15%
Earnings growth (this year)-20.53%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+255.67%
P/E ratioNM
Price/Sales14.31
Price/Book6.02

Competitors

 Today’s
change
Today’s
% change
ONVOOrganovo Holdings In...-0.01-0.23%
XBITXBiotech Inc+0.22+1.57%
NDRMNeuroderm Ltd+0.30+1.62%
VYGRVoyager Therapeutics...+0.46+3.22%
Data as of 4:02pm ET, 07/29/2016

Financials

Last reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$24.8M
Annual profit (last year)-$87.9M
Net profit margin-354.12%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Garo H. Armen
President-Research &
Development
Robert B. Stein
Corporate headquarters
Lexington, Massachusetts

Forecasts